PRELUDE CAPITAL MANAGEMENT, LLC - CORREVIO PHARMA CORP ownership

Back to all holdings Add to watchlist

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 36 filers reported holding CORREVIO PHARMA CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2019$216,000
-7.7%
108,1120.0%0.01%
-16.7%
Q2 2019$234,000
-39.7%
108,112
-12.0%
0.01%
-45.5%
Q1 2019$388,000
+128.2%
122,817
+79.9%
0.02%
+100.0%
Q4 2018$170,000–68,265–0.01%–
 Download
Other shareholders

There were no reported owners of CORREVIO PHARMA CORP in Q2 2019.

NameSharesValueWeighting ↓
View complete list of CORREVIO PHARMA CORP shareholders